Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial Dehydroepiandrosterone
Lust, John Anthony
Mayo Clinic, Rochester, Rochester, MN, United States
Search 4 grants from John Lust
Search grants from Mayo Clinic, Rochester
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Multi-scale Simulations of Bronic Acids in Prteasome Inhibition and Saccharide
Southwest Public Health Leadership Institute Border Health Leadership Program
Follow up of the PATS Sample
Cadherins in Mouse Olfactory Pathway Development
Surveillance, Epidemiology & End Results
Recently added grants:
Measuring Chronic Pain Impact
Mentoring and Research in Integrative Medicine
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and -caryophyllene
New Murine Models for Study of Atrophic Fracture Nonunion
Common and rare sequence variants in breast cancer risk
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN065125-000
Application #
2371351
Study Section
Project Start
1996-09-27
Project End
Budget Start
1996-09-27
Budget End
2001-09-29
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Related projects
NIH 2005
N01 CN
Phase 2 Clinical Trial-Dehydroepiandrosterone in Monoclonal Gammopathy-261065125
/ Mayo Clinic, Rochester
NIH 1996
N01 CN
Phase II Clinical Trial Dehydroepiandrosterone
Lust, John Anthony / Mayo Clinic, Rochester
Comments
Be the first to comment on this grant